Organization

IRCCS Policlinico S. Matteo

9 clinical trials

2 abstracts

Abstract
Comparison of antitumor efficacy of first-line palbociclib, ribociclib, or abemaciclib in patients with HR+/HER2- aBC: Results of the multicenter, real-world, Italian study PALMARES-2.
Org: IRCCS Policlinico S. Matteo, Dip Scienze Medico Chirurgiche Medicina, ICS Maugeri IRCCS, Ospedale di Mirano Dolo, ASST Fatebenefratelli Sacco,
Clinical trial
aMsa and amiOdarone Study in cArdiaC Arrest
Status: Completed, Estimated PCD: 2023-12-31
Abstract
GLS in Philadelphia-negative and JAK2 V617F-driven myeloproliferative neoplasms (MPNs).
Org: University of Chicago, Univeristy of Chicago, Policlinico San Matteo, University of Pavia, Fondazione I.R.C.C.S. Policlinico San Matteo,